Bfsg, LLC Gilead Sciences, Inc. Transaction History

Bfsg, LLC

$843 Million
Q3 2024

A detailed history of Bfsg, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bfsg, LLC holds 4,325 shares of GILD stock, worth $400,365. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,325

Previous 4,600 5.98%

Holding current value

$400,365

Previous $315,000 14.92%

% of portfolio

0.04%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$66.59 - $83.99 $18,312 - $23,097	-275 Reduced 5.98%	4,325 $362,000
Q2 2024 Jul 29, 2024	BUY	$63.15 - $72.88 $12,503 - $14,430	198 Added 4.5%	4,600 $315,000
Q1 2024 Apr 23, 2024	BUY	$71.58 - $87.29 $1,932 - $2,356	27 Added 0.62%	4,402 $322,000
Q4 2023 Feb 01, 2024	SELL	$73.27 - $83.09 $8,426 - $9,555	-115 Reduced 2.56%	4,375 $354,000
Q3 2023 Oct 20, 2023	BUY	$73.94 - $80.67 $331,990 - $362,208	4,490 New	4,490 $336,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $379,682 - $427,635	6,578 New	6,578 $407,000
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $190,293 - $215,986	-2,933 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $198,534 - $214,196	2,933 New	2,933 $205,000
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $2.36 Million - $2.96 Million	-37,954 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $46,659 - $54,180	-645 Reduced 1.67%	37,954 $2.92 Million
Q1 2020 Apr 27, 2020	SELL	$62.63 - $80.22 $344,151 - $440,808	-5,495 Reduced 12.46%	38,599 $2.89 Million
Q4 2019 Jan 29, 2020	BUY	$61.62 - $67.78 $144,190 - $158,605	2,340 Added 5.6%	44,094 $2.87 Million
Q3 2019 Oct 25, 2019	BUY	$62.51 - $69.0 $2.61 Million - $2.88 Million	41,754 New	41,754 $2.57 Million
Q3 2018 Oct 18, 2018	SELL	$71.28 - $78.92 $396,673 - $439,189	-5,565 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $44,796 - $54,612	-615 Reduced 9.95%	5,565 $420,000
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $159,731 - $187,502	-2,245 Reduced 26.65%	6,180 $443,000
Q3 2017 Oct 12, 2017	SELL	$72.11 - $85.47 $11,537 - $13,675	-160 Reduced 1.86%	8,425 $683,000
Q2 2017 Aug 10, 2017	BUY	N/A	8,585	8,585 $608,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.

Account